vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.

Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $40.3M, roughly 1.4× Cambium Networks Corp). Cambium Networks Corp runs the higher net margin — -17.9% vs -246.8%, a 228.8% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -23.2%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs -27.2%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.

CMBM vs VNDA — Head-to-Head

Bigger by revenue
VNDA
VNDA
1.4× larger
VNDA
$57.2M
$40.3M
CMBM
Growing faster (revenue YoY)
VNDA
VNDA
+30.7% gap
VNDA
7.6%
-23.2%
CMBM
Higher net margin
CMBM
CMBM
228.8% more per $
CMBM
-17.9%
-246.8%
VNDA
More free cash flow
CMBM
CMBM
$18.7M more FCF
CMBM
$-10.8M
$-29.5M
VNDA
Faster 2-yr revenue CAGR
VNDA
VNDA
Annualised
VNDA
9.8%
-27.2%
CMBM

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBM
CMBM
VNDA
VNDA
Revenue
$40.3M
$57.2M
Net Profit
$-7.2M
$-141.2M
Gross Margin
36.6%
Operating Margin
-28.4%
-70.5%
Net Margin
-17.9%
-246.8%
Revenue YoY
-23.2%
7.6%
Net Profit YoY
71.0%
-2774.3%
EPS (diluted)
$-0.26
$-2.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
VNDA
VNDA
Q4 25
$57.2M
Q3 25
$56.3M
Q2 25
$52.6M
Q1 25
$50.0M
Q4 24
$40.3M
$53.2M
Q3 24
$44.7M
$47.7M
Q2 24
$45.2M
$50.5M
Q1 24
$47.1M
$47.5M
Net Profit
CMBM
CMBM
VNDA
VNDA
Q4 25
$-141.2M
Q3 25
$-22.6M
Q2 25
$-27.2M
Q1 25
$-29.5M
Q4 24
$-7.2M
$-4.9M
Q3 24
$-34.5M
$-5.3M
Q2 24
$-14.2M
$-4.5M
Q1 24
$-18.4M
$-4.1M
Gross Margin
CMBM
CMBM
VNDA
VNDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
36.6%
Q3 24
43.6%
Q2 24
32.5%
Q1 24
29.8%
Operating Margin
CMBM
CMBM
VNDA
VNDA
Q4 25
-70.5%
Q3 25
-55.6%
Q2 25
-73.2%
Q1 25
-82.0%
Q4 24
-28.4%
-19.3%
Q3 24
-69.6%
-23.1%
Q2 24
-27.2%
-20.1%
Q1 24
-33.1%
-19.5%
Net Margin
CMBM
CMBM
VNDA
VNDA
Q4 25
-246.8%
Q3 25
-40.1%
Q2 25
-51.7%
Q1 25
-58.9%
Q4 24
-17.9%
-9.2%
Q3 24
-77.3%
-11.2%
Q2 24
-31.5%
-9.0%
Q1 24
-39.2%
-8.7%
EPS (diluted)
CMBM
CMBM
VNDA
VNDA
Q4 25
$-2.40
Q3 25
$-0.38
Q2 25
$-0.46
Q1 25
$-0.50
Q4 24
$-0.26
$-0.09
Q3 24
$-1.22
$-0.09
Q2 24
$-0.51
$-0.08
Q1 24
$-0.66
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
VNDA
VNDA
Cash + ST InvestmentsLiquidity on hand
$84.9M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-3.2M
$327.2M
Total Assets
$173.7M
$488.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
VNDA
VNDA
Q4 25
$84.9M
Q3 25
$70.0M
Q2 25
$81.0M
Q1 25
$111.8M
Q4 24
$102.3M
Q3 24
$100.5M
Q2 24
$103.0M
Q1 24
$125.2M
Total Debt
CMBM
CMBM
VNDA
VNDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$67.6M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Stockholders' Equity
CMBM
CMBM
VNDA
VNDA
Q4 25
$327.2M
Q3 25
$466.0M
Q2 25
$486.3M
Q1 25
$511.4M
Q4 24
$-3.2M
$538.5M
Q3 24
$1.9M
$541.2M
Q2 24
$34.1M
$542.5M
Q1 24
$45.0M
$544.0M
Total Assets
CMBM
CMBM
VNDA
VNDA
Q4 25
$488.9M
Q3 25
$601.1M
Q2 25
$624.7M
Q1 25
$631.9M
Q4 24
$173.7M
$656.2M
Q3 24
$194.3M
$645.1M
Q2 24
$221.1M
$651.4M
Q1 24
$219.8M
$652.7M
Debt / Equity
CMBM
CMBM
VNDA
VNDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
VNDA
VNDA
Operating Cash FlowLast quarter
$-10.4M
$-29.4M
Free Cash FlowOCF − Capex
$-10.8M
$-29.5M
FCF MarginFCF / Revenue
-26.8%
-51.6%
Capex IntensityCapex / Revenue
1.1%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$-110.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
VNDA
VNDA
Q4 25
$-29.4M
Q3 25
$-31.6M
Q2 25
$-15.3M
Q1 25
$-33.1M
Q4 24
$-10.4M
$-1.8M
Q3 24
$8.9M
$-14.6M
Q2 24
$2.4M
$-6.9M
Q1 24
$-15.9M
$7.6M
Free Cash Flow
CMBM
CMBM
VNDA
VNDA
Q4 25
$-29.5M
Q3 25
$-31.8M
Q2 25
$-15.6M
Q1 25
$-33.6M
Q4 24
$-10.8M
$-2.0M
Q3 24
$6.8M
$-14.7M
Q2 24
$87.0K
$-7.0M
Q1 24
$-17.4M
$7.6M
FCF Margin
CMBM
CMBM
VNDA
VNDA
Q4 25
-51.6%
Q3 25
-56.5%
Q2 25
-29.6%
Q1 25
-67.1%
Q4 24
-26.8%
-3.8%
Q3 24
15.2%
-30.9%
Q2 24
0.2%
-13.9%
Q1 24
-37.0%
15.9%
Capex Intensity
CMBM
CMBM
VNDA
VNDA
Q4 25
0.2%
Q3 25
0.3%
Q2 25
0.6%
Q1 25
0.9%
Q4 24
1.1%
0.4%
Q3 24
4.8%
0.3%
Q2 24
5.1%
0.2%
Q1 24
3.3%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

VNDA
VNDA

Fanapt$33.2M58%
Hetlioz$16.4M29%
PONVORY$7.6M13%

Related Comparisons